SEC 13F Intelligence

Omega Fund Management, LLC / NVLSEUR

Omega Fund Management, LLC’s Alpine Immune Sciences Inc Position

Does Omega Fund Management, LLC own Alpine Immune Sciences Inc (NVLSEUR)? Not currently — the last reported position was 153.7K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q3 2023
Shares
153.7K
% of Portfolio
+1.62%
Quarters Held
13
position exited

Position History NVLSEUR

Reported value by quarter
Q3 ’20: $11MQ3 ’20Q4 ’20: $16MQ1 ’21: $14MQ1 ’21Q2 ’21: $12MQ3 ’21: $22MQ3 ’21Q4 ’21: $28MQ1 ’22: $18MQ1 ’22Q2 ’22: $17MQ3 ’22: $15MQ3 ’22Q4 ’22: $15MQ1 ’23: $16MQ1 ’23Q2 ’23: $21MQ3 ’23: $2MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023153.7K$2M+1.62%
Q2 20232.03M$21M+11.69%
Q1 20232.03M$16M+10.22%
Q4 20222.03M$15M+5.03%
Q3 20222.03M$15M+5.35%
Q2 20222.03M$17M+5.51%
Q1 20222.03M$18M+3.73%
Q4 20212.03M$28M+3.97%
Q3 20212.03M$22M+1.45%
Q2 20211.28M$12M+1.91%
Q1 20211.28M$14M+1.86%
Q4 20201.28M$16M+2.43%
Q3 20201.28M$11M+3.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Omega Fund Management, LLC’s full portfolio or all institutional holders of NVLSEUR.